ConductScience.org, home
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
API referenceFor AI assistants

Trial · NCT03285308

Adverse events98

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

61 to 80 of 98

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousHyperglycaemiaMetabolism and nutrition disordersPlacebo1163
seriousHyperglycaemiaMetabolism and nutrition disordersRelamorelin 10 μg0163
seriousHyperglycaemic hyperosmolar nonketotic syndromeMetabolism and nutrition disordersPlacebo1163
seriousHyperglycaemic hyperosmolar nonketotic syndromeMetabolism and nutrition disordersRelamorelin 10 μg0163
seriousHypomagnesaemiaMetabolism and nutrition disordersPlacebo1163
seriousHypomagnesaemiaMetabolism and nutrition disordersRelamorelin 10 μg0163
seriousArthralgiaMusculoskeletal and connective tissue disordersPlacebo0163
seriousArthralgiaMusculoskeletal and connective tissue disordersRelamorelin 10 μg1163
seriousCervical spinal stenosisMusculoskeletal and connective tissue disordersPlacebo1163
seriousCervical spinal stenosisMusculoskeletal and connective tissue disordersRelamorelin 10 μg0163
seriousVertebral wedgingMusculoskeletal and connective tissue disordersPlacebo1163
seriousVertebral wedgingMusculoskeletal and connective tissue disordersRelamorelin 10 μg0163
seriousSyncopeNervous system disordersPlacebo0163
seriousSyncopeNervous system disordersRelamorelin 10 μg1163
seriousAcute kidney injuryRenal and urinary disordersPlacebo2163
seriousAcute kidney injuryRenal and urinary disordersRelamorelin 10 μg1163
seriousDiabetic nephropathyRenal and urinary disordersPlacebo1163
seriousDiabetic nephropathyRenal and urinary disordersRelamorelin 10 μg0163
seriousHydronephrosisRenal and urinary disordersPlacebo1163
seriousHydronephrosisRenal and urinary disordersRelamorelin 10 μg0163

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03285308/events?page=4

API referenceFor AI assistants